Zantac Archives - Mass Tort News

Zantac Litigation Overview

Article Provided by Brenden Leydon Attorney at Wocl Leydon LLC The litigation over the harmful effects of Zantac (generic name is Ranitidine) is just getting underway, and it looks like it will lead to a significant number of cases What is Zantac/Ranitidine Ranitidine is an antacid which belongs to a class of drugs known as histamine-2 receptor agonists (H2 blockers) This medication was also available without a prescription It was used as a common treatment used for ulcers, heartburn, indigestion, and gastroesophageal reflux disease (GERD) It works by effectively blocking histamine receptors in the...

FDA Issues Recall Statement On All Zantac (Ranitidine) Products

Mass Tort News Zantac April 1, 2020

FDA NEWS RELEASE FDA Requests Removal of All Ranitidine Products (Zantac) from the Market FDA Advises Consumers, Patients and Health Care Professionals After New FDA Studies Show Risk The US Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac) The agency has determined that the impurity in some...